Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ark Diagnostics Inc.

www.ark-tdm.com

Latest From Ark Diagnostics Inc.

Regulatory Pathway for Achaogen Looks Better; Is It Aimed At Viable Commercial Market?

With the FDA bottleneck for new anti-infectives showing signs of improvement, the next concern is whether providers will pay high premiums for new anti-infectives and the related challenge of finding the right patients to make high-cost treatments make sense.

BioPharmaceutical United States

Deals Update (01/2008)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ark Diagnostics Inc.
  • Senior Management
  • Johnny Valdez, Pres. & CEO
  • Contact Info
  • Ark Diagnostics Inc.
    Phone: (408) 747-0700
    1190 Bordeaux Dr.
    Sunnyvale, CA 94089-1209
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register